{"rows":[{"id":5775,"title":"Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.","authors":"Ippolito A, Tiranti A, Hurley S, Gilmour G, Churchill G, Sharp T","journal":"ACS chemical neuroscience","publication_date":"2026-08-05","publication_year":2026,"doi":"10.1021/acschemneuro.6c00138","pubmed_id":"42554671","openalex_id":"https://openalex.org/W7172419785","source_url":"https://pubmed.ncbi.nlm.nih.gov/42554671/","substance_tags":"psilocin","topic_tags":"Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-08-06 01:20:05","last_checked":"2026-08-12 01:20:06","bibtex":null,"source_record_id":"PMID:42554671","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42554671/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42554671","source_url":"https://pubmed.ncbi.nlm.nih.gov/42554671/","doi":"10.1021/acschemneuro.6c00138","pmid":"42554671","publication_date":"2026-08-05","importer_version":"2.1.3","text_redistributed":false}},{"id":2593,"title":"Animal models of serotonergic psychedelics.","authors":"Hanks JB, González-Maeso J","journal":"ACS chemical neuroscience","publication_date":"2013-01-16","publication_year":2013,"doi":"10.1021/cn300138m","pubmed_id":"23336043","openalex_id":"https://openalex.org/W2048184801","source_url":"https://pubmed.ncbi.nlm.nih.gov/23336043/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Animal Study","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:23336043","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/23336043/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:23336043","source_url":"https://pubmed.ncbi.nlm.nih.gov/23336043/","doi":"10.1021/cn300138m","pmid":"23336043","publication_date":"2013-01-16","importer_version":"2.1.3","text_redistributed":false}},{"id":2384,"title":"Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).","authors":"Nichols DE","journal":"ACS chemical neuroscience","publication_date":"2018-10-17","publication_year":2018,"doi":"10.1021/acschemneuro.8b00043","pubmed_id":"29461039","openalex_id":"https://openalex.org/W2788130744","source_url":"https://pubmed.ncbi.nlm.nih.gov/29461039/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Brain Imaging,Receptor Pharmacology,Consciousness,Aging,Mystical Experience,Clinical Trial,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:29461039","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29461039/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29461039","source_url":"https://pubmed.ncbi.nlm.nih.gov/29461039/","doi":"10.1021/acschemneuro.8b00043","pmid":"29461039","publication_date":"2018-10-17","importer_version":"2.1.3","text_redistributed":false}},{"id":2383,"title":"Psychedelics and Personality.","authors":"Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC","journal":"ACS chemical neuroscience","publication_date":"2018-10-17","publication_year":2018,"doi":"10.1021/acschemneuro.8b00237","pubmed_id":"29863323","openalex_id":"https://openalex.org/W2805186158","source_url":"https://pubmed.ncbi.nlm.nih.gov/29863323/","substance_tags":"psilocybin","topic_tags":"Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Personality Change,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:29863323","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29863323/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29863323","source_url":"https://pubmed.ncbi.nlm.nih.gov/29863323/","doi":"10.1021/acschemneuro.8b00237","pmid":"29863323","publication_date":"2018-10-17","importer_version":"2.1.3","text_redistributed":false}},{"id":2382,"title":"DARK Classics in Chemical Neuroscience: Psilocybin.","authors":"Geiger HA, Wurst MG, Daniels RN","journal":"ACS chemical neuroscience","publication_date":"2018-10-17","publication_year":2018,"doi":"10.1021/acschemneuro.8b00186","pubmed_id":"29956917","openalex_id":"https://openalex.org/W2810710828","source_url":"https://pubmed.ncbi.nlm.nih.gov/29956917/","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Addiction,End-of-Life Distress,Pharmacology,Review Article,Cancer Patients","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:29956917","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29956917/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29956917","source_url":"https://pubmed.ncbi.nlm.nih.gov/29956917/","doi":"10.1021/acschemneuro.8b00186","pmid":"29956917","publication_date":"2018-10-17","importer_version":"2.1.3","text_redistributed":false}},{"id":2381,"title":"Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).","authors":"Cameron LP, Olson DE","journal":"ACS chemical neuroscience","publication_date":"2018-10-17","publication_year":2018,"doi":"10.1021/acschemneuro.8b00101","pubmed_id":"30036036","openalex_id":"https://openalex.org/W2883970814","source_url":"https://pubmed.ncbi.nlm.nih.gov/30036036/","substance_tags":"psilocybin","topic_tags":"Pharmacology,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:30036036","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/30036036/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:30036036","source_url":"https://pubmed.ncbi.nlm.nih.gov/30036036/","doi":"10.1021/acschemneuro.8b00101","pmid":"30036036","publication_date":"2018-10-17","importer_version":"2.1.3","text_redistributed":false}},{"id":2380,"title":"DARK Classics in Chemical Neuroscience: Ibogaine.","authors":"Wasko MJ, Witt-Enderby PA, Surratt CK","journal":"ACS chemical neuroscience","publication_date":"2018-10-17","publication_year":2018,"doi":"10.1021/acschemneuro.8b00294","pubmed_id":"30216039","openalex_id":"https://openalex.org/W2891949993","source_url":"https://pubmed.ncbi.nlm.nih.gov/30216039/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Receptor Pharmacology,Clinical Trial,Animal Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:30216039","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/30216039/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:30216039","source_url":"https://pubmed.ncbi.nlm.nih.gov/30216039/","doi":"10.1021/acschemneuro.8b00294","pmid":"30216039","publication_date":"2018-10-17","importer_version":"2.1.3","text_redistributed":false}},{"id":2289,"title":"Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression.","authors":"Hibicke M, Landry AN, Kramer HM, Talman ZK, Nichols CD","journal":"ACS chemical neuroscience","publication_date":"2020-03-18","publication_year":2020,"doi":"10.1021/acschemneuro.9b00493","pubmed_id":"32133835","openalex_id":"https://openalex.org/W3010499243","source_url":"https://pubmed.ncbi.nlm.nih.gov/32133835/","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Animal Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32133835","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32133835/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32133835","source_url":"https://pubmed.ncbi.nlm.nih.gov/32133835/","doi":"10.1021/acschemneuro.9b00493","pmid":"32133835","publication_date":"2020-03-18","importer_version":"2.1.3","text_redistributed":false}},{"id":2275,"title":"Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances.","authors":"Abbott KL, Gill KS, Flannery PC, Boothe DM, Dhanasekaran M, Pondugula SR","journal":"ACS chemical neuroscience","publication_date":"2020-05-20","publication_year":2020,"doi":"10.1021/acschemneuro.0c00241","pubmed_id":"32395981","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/32395981/","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Receptor Pharmacology,Toxicity","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32395981","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32395981/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32395981","source_url":"https://pubmed.ncbi.nlm.nih.gov/32395981/","doi":"10.1021/acschemneuro.0c00241","pmid":"32395981","publication_date":"2020-05-20","importer_version":"2.1.3","text_redistributed":false}},{"id":2235,"title":"Polypharmacology or \"Pharmacological Promiscuity\" In Psychedelic Research: What Are We Missing?","authors":"Ona GS, Dos Santos RG, Hallak JEC, Bouso JC","journal":"ACS chemical neuroscience","publication_date":"2020-10-21","publication_year":2020,"doi":"10.1021/acschemneuro.0c00614","pubmed_id":"33021777","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/33021777/","substance_tags":"psilocybin","topic_tags":"Pharmacology","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33021777","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33021777/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33021777","source_url":"https://pubmed.ncbi.nlm.nih.gov/33021777/","doi":"10.1021/acschemneuro.0c00614","pmid":"33021777","publication_date":"2020-10-21","importer_version":"2.1.3","text_redistributed":false}},{"id":2224,"title":"DARK Classics in Chemical Neuroscience: NBOMes.","authors":"Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL","journal":"ACS chemical neuroscience","publication_date":"2020-12-02","publication_year":2020,"doi":"10.1021/acschemneuro.9b00528","pubmed_id":"31657895","openalex_id":"https://openalex.org/W2981860490","source_url":"https://pubmed.ncbi.nlm.nih.gov/31657895/","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology,Review Article,Safety,Toxicity","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:31657895","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31657895/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31657895","source_url":"https://pubmed.ncbi.nlm.nih.gov/31657895/","doi":"10.1021/acschemneuro.9b00528","pmid":"31657895","publication_date":"2020-12-02","importer_version":"2.1.3","text_redistributed":false}},{"id":1697,"title":"Skepticism about Recent Evidence That Psilocybin \"Liberates\" Depressed Minds.","authors":"Doss MK, Barrett FS, Corlett PR","journal":"ACS chemical neuroscience","publication_date":"2022-09-07","publication_year":2022,"doi":"10.1021/acschemneuro.2c00461","pubmed_id":"36001741","openalex_id":"https://openalex.org/W4293101872","source_url":"https://pubmed.ncbi.nlm.nih.gov/36001741/","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Receptor Pharmacology,Aging,Drug Interactions","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:19","bibtex":null,"source_record_id":"PMID:36001741","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36001741/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36001741","source_url":"https://pubmed.ncbi.nlm.nih.gov/36001741/","doi":"10.1021/acschemneuro.2c00461","pmid":"36001741","publication_date":"2022-09-07","importer_version":"2.1.3","text_redistributed":false}},{"id":1569,"title":"5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.","authors":"Cameron LP, Patel SD, Vargas MV, Barragan EV, Saeger HN, Warren HT, Chow WL, Gray JA, Olson DE","journal":"ACS chemical neuroscience","publication_date":"2023-02-01","publication_year":2023,"doi":"10.1021/acschemneuro.2c00718","pubmed_id":"36630260","openalex_id":"https://openalex.org/W4315620747","source_url":"https://pubmed.ncbi.nlm.nih.gov/36630260/","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Pharmacology,Receptor Pharmacology,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:17","bibtex":null,"source_record_id":"PMID:36630260","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36630260/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36630260","source_url":"https://pubmed.ncbi.nlm.nih.gov/36630260/","doi":"10.1021/acschemneuro.2c00718","pmid":"36630260","publication_date":"2023-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1253,"title":"Psychedelic-like Activity of Norpsilocin Analogues.","authors":"Sherwood AM, Burkhartzmeyer EK, Williamson SE, Baumann MH, Glatfelter GC","journal":"ACS chemical neuroscience","publication_date":"2024-01-17","publication_year":2024,"doi":"10.1021/acschemneuro.3c00610","pubmed_id":"38189238","openalex_id":"https://openalex.org/W4390671187","source_url":"https://pubmed.ncbi.nlm.nih.gov/38189238/","substance_tags":"psilocybin,psilocin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study,Drug Interactions","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:10","bibtex":null,"source_record_id":"PMID:38189238","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38189238/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38189238","source_url":"https://pubmed.ncbi.nlm.nih.gov/38189238/","doi":"10.1021/acschemneuro.3c00610","pmid":"38189238","publication_date":"2024-01-17","importer_version":"2.1.3","text_redistributed":false}},{"id":1104,"title":"RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-,-diisopropyltryptamine.","authors":"Bryson N, Alexander R, Asnis-Alibozek A, Ehlers MD","journal":"ACS chemical neuroscience","publication_date":"2024-06-19","publication_year":2024,"doi":"10.1021/acschemneuro.4c00058","pubmed_id":"38758589","openalex_id":"https://openalex.org/W4396988535","source_url":"https://pubmed.ncbi.nlm.nih.gov/38758589/","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Receptor Pharmacology,Clinical Trial,Animal Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:38758589","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38758589/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38758589","source_url":"https://pubmed.ncbi.nlm.nih.gov/38758589/","doi":"10.1021/acschemneuro.4c00058","pmid":"38758589","publication_date":"2024-06-19","importer_version":"2.1.3","text_redistributed":false}},{"id":1075,"title":"Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A.","authors":"Bagdasarian FA, Hansen HD, Chen J, Yoo CH, Placzek MS, Hooker JM, Wey HY","journal":"ACS chemical neuroscience","publication_date":"2024-07-17","publication_year":2024,"doi":"10.1021/acschemneuro.4c00245","pubmed_id":"38916752","openalex_id":"https://openalex.org/W4400002012","source_url":"https://pubmed.ncbi.nlm.nih.gov/38916752/","substance_tags":"psilocybin","topic_tags":"Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:38916752","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38916752/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38916752","source_url":"https://pubmed.ncbi.nlm.nih.gov/38916752/","doi":"10.1021/acschemneuro.4c00245","pmid":"38916752","publication_date":"2024-07-17","importer_version":"2.1.3","text_redistributed":false}},{"id":702,"title":"Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.","authors":"Wang H, Wang X","journal":"ACS chemical neuroscience","publication_date":"2025-05-07","publication_year":2025,"doi":"10.1021/acschemneuro.5c00247","pubmed_id":"40254808","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40254808/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Default Mode Network,Aging,Emotional Processing","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:59","bibtex":null,"source_record_id":"PMID:40254808","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40254808/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40254808","source_url":"https://pubmed.ncbi.nlm.nih.gov/40254808/","doi":"10.1021/acschemneuro.5c00247","pmid":"40254808","publication_date":"2025-05-07","importer_version":"2.1.3","text_redistributed":false}},{"id":652,"title":"Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.","authors":"Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A","journal":"ACS chemical neuroscience","publication_date":"2025-06-18","publication_year":2025,"doi":"10.1021/acschemneuro.5c00152","pubmed_id":"40474592","openalex_id":"https://openalex.org/W4411103150","source_url":"https://pubmed.ncbi.nlm.nih.gov/40474592/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Inflammation","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:40474592","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40474592/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40474592","source_url":"https://pubmed.ncbi.nlm.nih.gov/40474592/","doi":"10.1021/acschemneuro.5c00152","pmid":"40474592","publication_date":"2025-06-18","importer_version":"2.1.3","text_redistributed":false}},{"id":573,"title":"Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications.","authors":"Wang X, Jun F, Lin C, Wang X","journal":"ACS chemical neuroscience","publication_date":"2025-08-06","publication_year":2025,"doi":"10.1021/acschemneuro.5c00418","pubmed_id":"40631920","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40631920/","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Microbiome,Inflammation","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:57","bibtex":null,"source_record_id":"PMID:40631920","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40631920/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40631920","source_url":"https://pubmed.ncbi.nlm.nih.gov/40631920/","doi":"10.1021/acschemneuro.5c00418","pmid":"40631920","publication_date":"2025-08-06","importer_version":"2.1.3","text_redistributed":false}},{"id":572,"title":"Psychedelics, Spirituality, and Fundamentalism: A Brain Network Approach to Cognitive Flexibility and Rigidity.","authors":"Yang A, Lv X, Wang H, Wang X","journal":"ACS chemical neuroscience","publication_date":"2025-08-06","publication_year":2025,"doi":"10.1021/acschemneuro.5c00509","pubmed_id":"40702747","openalex_id":"https://openalex.org/W4412641880","source_url":"https://pubmed.ncbi.nlm.nih.gov/40702747/","substance_tags":"psilocybin","topic_tags":"Spirituality,Mystical Experience","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:57","bibtex":null,"source_record_id":"PMID:40702747","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40702747/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40702747","source_url":"https://pubmed.ncbi.nlm.nih.gov/40702747/","doi":"10.1021/acschemneuro.5c00509","pmid":"40702747","publication_date":"2025-08-06","importer_version":"2.1.3","text_redistributed":false}}],"total":25,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"ACS chemical neuroscience","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}